C71T
CANCELLED SECTION 71
08/14/2026
Back to search
Official data from USPTO
TULIP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
08/14/2026
Trademark type
Word
Nice classes
41, 42
Filing date
03/05/2018
Registration date
01/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/14/2026
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
NL
Examiner
LAM, HAI-LY HUYNH
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BYONDIS B.V.
Synthon Biopharmaceuticals B.V
Representatives
E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC
Technical classification
Nice Classes
Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Publication of journalsnewsletters and scientific papers all featuring the results of clinical trials in the field of anticancer drugs; publication of journalsnewsletters and scientific papers all featuring results of clinical trials for pharmaceutical preparations
Class 42
Performing clinical trials for others relating to pharmaceutical products in the field of anticancer drugs; providing medical and scientific research information on clinical trials in the field of anticancer medicines through an interactive website; providing medical and scientific research information in the field of pharmaceutical products and clinical trials in the field of anticancer drugs; conducting clinical trials for third parties in the field of anticancer drugs; conducting clinical trials for others; performing clinical trials for others in the field of pharmaceutical products; provision of information about the results of clinical trials for pharmaceutical products for scientific and medical research purposes; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing medical and scientific research information about clinical studies via an interactive website; all of the above services directed to pharmaceutical companies
Publications
History of USPTO decisions and trademark events.
48 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/28/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/21/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/11/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/29/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2020
FIMP
FINAL DISPOSITION PROCESSED
05/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2019
PUBO
PUBLISHED FOR OPPOSITION
11/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
11/08/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/01/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/16/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/16/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/17/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/10/2019
GNFR
FINAL REFUSAL E-MAILED
07/10/2019
CNFR
FINAL REFUSAL WRITTEN
07/10/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/20/2019
ALIE
ASSIGNED TO LIE
06/13/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/15/2018
GNSL
LETTER OF SUSPENSION E-MAILED
11/15/2018
CNSL
SUSPENSION LETTER WRITTEN
11/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/24/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/24/2018
RFNT
REFUSAL PROCESSED BY IB
07/21/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/05/2018
RFRR
REFUSAL PROCESSED BY MPU
07/05/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/23/2018
CNRT
NON-FINAL ACTION WRITTEN
06/22/2018
DOCK
ASSIGNED TO EXAMINER
06/15/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/22/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/10/2018
Continuous trademark protection
Get notified about every new filing that threatens TULIP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.